Specific post-marketing surveillance of garenoxacin (Geninax)
Not Applicable
- Conditions
- egionella pneumonia
- Registration Number
- JPRN-jRCT1080222731
- Lead Sponsor
- Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Registered patients in Japanese Society of Chemotherapy the committee of evaluation of legionella pneumonia on or after May 7, 2008
Exclusion Criteria
1.Patients with a history of hypersensitivity to any of the ingredients of this product or quinolone antibacterial agents.
2.Pregnant women or women who may become pregnant
3.Children
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method